pharma · Progressive supranuclear palsy (PSP) · Amyotrophic Lateral Sclerosis
Dr. Ferrer BioPharma
Ferrer Internacional S.A.
Ferrer Internacional is a pharma organization headquartered in Barcelona, ES. Primary therapeutic focus areas include Progressive supranuclear palsy (PSP), Amyotrophic Lateral Sclerosis. NovaPharmaNews links 2 clinical p
Hallandale Beach, USA HQ
2020 Founded
11 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Hallandale Beach, USA
- Founded
- 2020
- Employees
- 11
- Programs
- 2
- Drugs
- 2
- Patents
- 0
FNP-223, Film coated tabled
Phase 2 · small molecule · Progressive supranuclear palsy (PSP)
FNP-223, Film coated tabled for Progressive supranuclear palsy (PSP) is a Phase 2 program (small_molecule) at Ferrer Internacional S.A. with 1 ClinicalTrials.gov record(s).
Internal code FNP223-CT-2301
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Ferrer Internacional S.A.
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Progressive supranuclear palsy (PSP)
- Status
- active
- Trials
- 1